MEA Specialty Enzymes Market

Middle East and Africa Specialty Enzymes Market Size (2024 to 2029)

The specialty enzymes market in the Middle East and Africa is forecasted to grow at a sluggish CAGR between 2024 and 2029.

The rising use of specialty enzymes in various diagnostic tests for cancer, diabetes, and heart diseases is a key driver driving the growth of the Middle East and Africa specialty enzymes market. In addition, specialty enzymes also aid in the production of low-cost medications and treatments by increasing manufacturing efficiencies. Therefore, the increasing demand for non-harmful biological catalysts in pharmaceuticals and diagnostics is expected to boost the market growth in MEA. On the other hand, the usage of specialized enzymes in fine chemicals as a biocatalyst for rapid reactions is a significant factor driving the Middle East and Africa specialty enzymes market over the forecast period.

The use of specialty enzymes increased significantly throughout the forecast period due to the increasing use of new techniques to optimize pharmaceutical production and people's concerns about quality. Moreover, the multifunctional benefits of specialty enzymes in various applications and technological developments to reduce the consumption of chemical catalysts are propelling the specialty enzyme market forward. In addition, custom enzymes have grown in popularity due to the development of tools to optimize pharmaceutical production and customer concerns about quality.

Specialty enzymes have a wide range of applications throughout the region; however, the leading players use various strategies to expand regional market growth. Furthermore, industry participants are developing advanced and innovative phytase enzymes and insisting for FDA and Center for Veterinary Medicine approval to utilize the product in animal feed diets.

The specialized enzyme market in the MEA region is growing due to the multifunctional benefits of specialty enzymes in various applications and technological advancements that reduce the use of chemical catalysts. Furthermore, specialty enzymes are in great demand because of the increased use of enzymes in pharmaceutical companies. Specialty enzymes are commonly used in the pharmaceutical sector for medicine production, disease diagnosis, and therapy. The rising use of enzymes in cancer, cardiovascular disease, lysosomal storage disorders, and pain and inflammation control is one factor driving the market growth.

However, the high cost of diagnostics solutions for chronic diseases in emerging countries, and lack of awareness regarding diagnostic tests, on the other hand, are the major factors hampering the specialty enzymes market growth in the MEA region.

This research report on the MEA specialty enzymes market has been segmented and sub-segmented into the following categories.

Middle East and Africa Specialty Enzymes Market - By Source

• Microorganism
• Plant
• Animal

Middle East and Africa Specialty Enzymes Market - By Type

• Protease
• Lipase
• Carbohydrases
• Polymerases
• Nucleases

Middle East and Africa Specialty Enzymes Market - By Application

• Research & Biotechnology
• Diagnostic
• Pharmaceutical
• Biocatalyst

Middle East and Africa Specialty Enzymes Market - By Country

• KSA
• UAE
• Israel
• rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• rest of MEA

The Middle East and Africa have an untapped market, and key players are slowly expanding to this region, which is the main reason for the market's growth in this region.

The specialty enzymes market in the Middle East and Africa had a moderate percentage of the global market in 2020. However, it is projected to record a promising share during the forecast period. Enzymes are now available for a wide range of applications due to technological improvements in the region, which is expected to boost the market's expansion. The region is expected to see the emergence of unique and superior-performing items and the industrialization of the Middle East and Africa. South Africa, Saudi Arabia, UAE, and Kuwait are the leading countries expanding regional market growth.

South Africa accounted for the largest share of the market due to a significant number of biopharmaceutical companies, improving healthcare infrastructure, and favorable government regulations.

The UAE is more likely to witness a significant share of the market. The market growth is expected to be driven by new product launches with broader applications, growing awareness, improving the pharmaceutical sector, and increasing its R&D investments.

KEY MARKET PLAYERS

A few of the noteworthy companies operating in the MEA specialty enzymes market profiled in the report are Bbi Enzymes Ltd., BASF, Codexis Inc., Nagase & Co. Ltd., Life Technologies, Advanced Enzyme Technology Ltd. Affymetrix Inc., Advanced Enzyme Technology Ltd., Amano Enzyme Inc., Roche Holding Ag., and Sanofi S.A.